Drug Type Synthetic peptide |
Synonyms- |
Target |
Action- |
Mechanism orexin agonists(hypocretin neuropeptide precursor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anesthesia | Discovery | - | 16 Feb 2023 | |
Endocrinology and Metabolic Disease | Discovery | - | 16 Feb 2023 | |
Genetic Diseases, Inborn | Discovery | - | 16 Feb 2023 | |
Heart Failure | Discovery | - | 16 Feb 2023 | |
Nervous System Diseases | Discovery | - | 16 Feb 2023 |